Artiva Biotherapeutics Stock (NASDAQ: ARTV) stock price, news, charts, stock research, profile.
You can purchase shares of Artiva Biotherapeutics (NASDAQ:ARTV) through any online brokerage.
Other companies in Artiva Biotherapeutics’s space includes: Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL), Larimar Therapeutics (NASDAQ:LRMR) and Fate Therapeutics (NASDAQ:FATE).
Artiva Biotherapeutics has a consensus price target of $21.00.
The stock price for Artiva Biotherapeutics (NASDAQ: ARTV) is $10.67 last updated January 3, 2025 at 4:01 PM EST.
There are no upcoming dividends for Artiva Biotherapeutics.
Artiva Biotherapeutics’s Q4 earnings are confirmed for Saturday, February 22, 2025.
There is no upcoming split for Artiva Biotherapeutics.
Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.